Health Catalyst, Inc (HCAT) Fair Value 2026

HCAT · Services-Computer Programming, Data Processing, Etc. ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.4 /10

32 fundamental signals · 12 models active

Value Trap Risk

LOW (25/100)

Quick Summary — As of 2026-07-15, Health Catalyst, Inc (HCAT) trades at $2.33, approximately 7% below CirclFi’s Bayesian DCF fair value of $2.49. QOC: 6.4/10. Value Trap Risk: 25/100 (LOW). 12/13 models active.

Key Facts

Ticker
HCAT
Price
$2.33
Quality Score
6.4/10
Value Trap Risk
25/100
Models Active
12/13
Last Updated
Strength: CUCE Ensemble suggests +82.5% upside with 3% confidence
Risk: Limited model coverage (12/13) may reduce confidence

Is Health Catalyst, Inc (HCAT) Undervalued or Overvalued in 2026?

According to CirclFi’s 12-model valuation engine, Health Catalyst, Inc (HCAT) appears undervalued as of : the median of 12 independent fair value estimates is $2.59, 11.3% above the current price of $2.33. Estimates range from $0.21 to $9.70. HCAT scores 6.4/10 on fundamental quality and 25/100 on value-trap risk.

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Health Catalyst, Inc Stock in 2026? →

Valuation Matrix

12 Intrinsic Value Models vs. Current Price ($2.33)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
 $2.49 +7.0%
CUCE Ensemble
Low Conviction
 $4.25 +82.5%
First Chicago
Medium Conviction
 $3.66 +57.1%
Dynamic NAV
High Conviction
 $0.99 -57.3%

Unlock the Full Matrix

Access 8 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 12 Models →

Cancel anytime · No contracts · Instant access

What Is Health Catalyst, Inc (HCAT) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for Health Catalyst, Inc. Trading at $2.33 against an estimated intrinsic value of $3.19, 9 of 12 active models flag meaningful upside of +36.9% on average. The most optimistic model, EROIC, places fair value at $9.70 (+316.5%), while Markov DDM — the most conservative — estimates $0.21 (-90.8%). This +407.3% gap reflects genuine analytical uncertainty about Health Catalyst, Inc's intrinsic worth.

What Do the Models Say About HCAT?

12 of 13 models are currently active for HCAT. Of these, 9 models suggest upside while 3 models suggest overvaluation. The Bayesian DCF estimates HCAT's intrinsic value at $2.49, implying +7.0% upside from the current price. See which stocks rank higher →

How Does HCAT Rank in Services-Computer Programming, Data Processing, Etc.?

Among 75 Services-Computer Programming, Data Processing, Etc. stocks, HCAT ranks #40 by Quality of Company score. CirclFi's QOC score of 6.4/10 evaluates 32 fundamental signals. A score of 6.4 indicates above-average quality.

See all Most Undervalued Services-Computer Programming, Data Processing, Etc. Stocks →

Health Catalyst, Inc operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is HCAT a Value Trap?

CirclFi's Value Trap algorithm assigns HCAT a score of 25/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

12 of 13 models are active for Health Catalyst, Inc. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Health Catalyst, Inc scores 6.4 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +407.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every HCAT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across HCAT's 12 active models, average confidence is 33%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Health Catalyst, Inc Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Services-Computer Programming, Data Processing, Etc. Stocks Should You Also Analyze?

8 related Services-Computer Programming, Data Processing, Etc. stocks with 13-model coverage

GOOGAlphabet Inc.QOC 10.0GOOGLAlphabet Inc.QOC 10.0TTDThe Trade Desk, Inc.QOC 10.0BZKANZHUN LIMITED - American DepoQOC 10.0BIDUBaidu, Inc.QOC 9.8FDSFactSet Research Systems Inc.QOC 9.8HSTMHealthStream, Inc.QOC 9.6EVEREverQuote, Inc.QOC 9.3

Read investment analysis: GOOG · GOOGL · TTD · BZ · BIDU

See all Services-Computer Programming, Data Processing, Etc. stocks ranked →

Frequently Asked Questions About Health Catalyst, Inc

What is Health Catalyst, Inc's intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Health Catalyst, Inc (HCAT) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $2.49. The Quality of Company score is 6.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is HCAT overvalued or undervalued right now?

At $2.33, 9 of 12 active models suggest HCAT may be undervalued, while 3 indicate potential overvaluation. The median of all 12 fair value estimates is $2.59, 11.3% above the current price of $2.33 — a consensus view that HCAT is undervalued. The assessment depends on which methodology best fits Health Catalyst, Inc's business model in Services-Computer Programming, Data Processing, Etc..

What does a Quality of Company score of 6.4 mean for HCAT?

Health Catalyst, Inc's QOC of 6.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on HCAT?

CirclFi analyzes HCAT with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 12 of 13 are active for this stock. Read the full methodology →

Is HCAT a value trap in 2026?

Health Catalyst, Inc's Value Trap score is 25/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 12-model valuation engine, Health Catalyst, Inc (HCAT) has a median fair value of $2.59 — 11.3% above the current price of $2.33 — as of 2026-07-15.” Source: circlfi.com/stock/HCAT/ · Methodology

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 12 mathematical frameworks give you clarity on HCAT.

Unlock All 12 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access